Deutsche Bank AG Acquires 14,929 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Deutsche Bank AG boosted its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 51.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 43,809 shares of the company's stock after purchasing an additional 14,929 shares during the quarter. Deutsche Bank AG owned about 0.09% of Prestige Consumer Healthcare worth $3,421,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in PBH. Cetera Investment Advisers acquired a new position in Prestige Consumer Healthcare in the fourth quarter valued at about $413,000. Bank of America Corp DE increased its stake in Prestige Consumer Healthcare by 6.4% during the 4th quarter. Bank of America Corp DE now owns 594,098 shares of the company's stock worth $46,393,000 after purchasing an additional 35,830 shares in the last quarter. BNP Paribas Financial Markets raised its holdings in Prestige Consumer Healthcare by 1,073.3% during the 4th quarter. BNP Paribas Financial Markets now owns 203,903 shares of the company's stock worth $15,923,000 after buying an additional 186,524 shares during the period. Lido Advisors LLC acquired a new stake in Prestige Consumer Healthcare during the 4th quarter worth approximately $226,000. Finally, Northern Trust Corp boosted its holdings in shares of Prestige Consumer Healthcare by 10.9% in the fourth quarter. Northern Trust Corp now owns 813,076 shares of the company's stock valued at $63,493,000 after buying an additional 80,055 shares during the period. Institutional investors and hedge funds own 99.95% of the company's stock.

Insider Activity

In other news, SVP Mary Beth Fritz sold 1,678 shares of the company's stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $90.00, for a total transaction of $151,020.00. Following the transaction, the senior vice president now directly owns 17,157 shares of the company's stock, valued at $1,544,130. This represents a 8.91% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 1.60% of the company's stock.

Wall Street Analysts Forecast Growth

PBH has been the subject of several recent research reports. Wall Street Zen raised Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a research report on Saturday, May 17th. Royal Bank of Canada upgraded shares of Prestige Consumer Healthcare to a "hold" rating in a research note on Thursday, May 8th. Oppenheimer boosted their price target on Prestige Consumer Healthcare from $87.00 to $93.00 and gave the stock an "outperform" rating in a research report on Thursday, February 13th. Canaccord Genuity Group increased their price objective on Prestige Consumer Healthcare from $93.00 to $100.00 and gave the company a "buy" rating in a report on Friday, February 7th. Finally, DA Davidson boosted their target price on shares of Prestige Consumer Healthcare from $95.00 to $104.00 and gave the stock a "buy" rating in a report on Friday, February 7th. Three equities research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $93.33.

Prestige Consumer Healthcare Stock Performance

Shares of PBH stock traded up $0.97 during midday trading on Friday, hitting $85.98. 341,432 shares of the company were exchanged, compared to its average volume of 297,874. The company has a debt-to-equity ratio of 0.56, a quick ratio of 2.20 and a current ratio of 3.68. The firm has a market capitalization of $4.25 billion, a P/E ratio of 20.14, a PEG ratio of 2.69 and a beta of 0.44. The firm's 50 day moving average price is $83.52 and its two-hundred day moving average price is $82.28. Prestige Consumer Healthcare Inc. has a 52 week low of $62.35 and a 52 week high of $90.04.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last released its earnings results on Thursday, May 8th. The company reported $1.32 earnings per share for the quarter, beating analysts' consensus estimates of $1.30 by $0.02. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%. The firm had revenue of $296.52 million during the quarter, compared to the consensus estimate of $289.36 million. During the same period in the prior year, the company posted $1.02 EPS. The company's revenue was up 7.0% compared to the same quarter last year. As a group, equities research analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current year.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.